Goldman Sachs Group Inc Accelerate Diagnostics, Inc Transaction History

Goldman Sachs Group Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 May 14, 2024	BUY	$0.51 - $17.1 $5,013 - $168,093	9,830 Added 33.85%	38,873 $27,000
Q4 2022 Feb 13, 2023	BUY	$0.51 - $17.1 $5,013 - $168,093	9,830 Added 33.85%	38,873 $27,000
Q3 2022 May 14, 2024	SELL	$1.01 - $17.0 $16,946 - $285,243	-16,779 Reduced 36.62%	29,043 $44,000
Q3 2022 Nov 10, 2022	SELL	$1.01 - $17.0 $16,946 - $285,243	-16,779 Reduced 36.62%	29,043 $0
Q2 2022 May 14, 2024	BUY	$0.54 - $1.41 $24,743 - $64,609	45,822 New	45,822 $45,000
Q2 2022 Aug 15, 2022	SELL	$0.54 - $1.41 $27,545 - $71,924	-51,010 Reduced 52.68%	45,822 $45,000
Q1 2022 May 16, 2022	BUY	$1.4 - $5.15 $81,356 - $299,276	58,112 Added 150.08%	96,832 $139,000
Q4 2021 Feb 14, 2022	BUY	$4.27 - $6.97 $110,524 - $180,411	25,884 Added 201.65%	38,720 $202,000
Q3 2021 Nov 10, 2021	BUY	$5.31 - $8.25 $68,159 - $105,897	12,836 New	12,836 $75,000

549K

Ticker AXDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 99,059,904
Market Cap $125M
Description
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.